Search Within

Jan Philipp Bewersdorf

Formats
  1. Meeting Abstract (40)
  2. Journal Article (26)
  3. Review (21)
  4. Research Letter (7)
  5. Correspondence (4)
  6. Editorial (4)
  7. Guidelines (1)
Groups
  1. GME, Medicine (103)
  2. Graduate Medical Education (103)
  3. Hematology-Oncology Fellows (103)
  4. Center for Hematologic Malignancies (60)
  5. Department of Medicine (60)
  6. Hematologic Malignancies, Division of (60)

More Groups

People
  1. Eytan Stein (33)
  2. Aaron Goldberg (20)
  3. Omar Abdel-Wahab (15)
  4. Andriy Derkach (14)
  5. Raajit Rampal (9)
  6. Maximilian Stahl (5)

More People

Years
  1. 2025 (7)
  2. 2024 (26)
  3. 2023 (42)
  4. 2022 (25)
  5. 2021 (3)
Publications
  1. Blood (41)
  2. Leukemia and Lymphoma (7)
  3. Leukemia (6)
  4. Blood Reviews (5)
  5. Journal of Clinical Oncology (4)
  6. American Journal of Hematology (3)

More Publications

Publishers
  1. American Society of Hematology (43)
  2. Nature Publishing Group (8)
  3. Taylor & Francis Group (8)
  4. American Society of Clinical Oncology (5)
  5. Churchill Livingstone (5)
  6. Elsevier Inc. (4)

More Publishers

Results (103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
    Journal Article

    Tanaka, A.; Nakano, T. A.; Nomura, M.; Yamazaki, H.; Bewersdorf, J. P.; Mulet-Lazaro, R.; Hogg, S.; Liu, B.; Penson, A.; Yokoyama, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells
    Journal Article

    North, K.; Benbarche, S.; Liu, B.; Pangallo, J.; Chen, S.; Stahl, M.; Bewersdorf, J. P.; Stanley, R. F.; Erickson, C.; Cho, H.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy
    Correspondence

    Zeidan, A. M.; Fenaux, P.; Gobbi, M.; Mayer, J.; Roboz, G. J.; Krauter, J.; Robak, T.; Kantarjian, H. M.; Novák, J.; Jedrzejczak, W. W.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Are we moving the needle for patients with TP53-mutated acute myeloid leukemia?
    Review

    Shallis, R. M.; Bewersdorf, J. P.; Stahl, M. F.; Halene, S.; Zeidan, A. M.
    Cancers (2022)

    Fulltext@MSK | Save
  • Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic
    Review

    Bewersdorf, J. P.; Abdel-Wahab, O.
    Genes and Development (2022)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cells: A grey eminence in the AML tumor microenvironment?
    Editorial

    Bewersdorf, J. P.; Zeidan, A. M.
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia
    Research Letter

    Bewersdorf, J. P.; Patel, K. K.; Goshua, G.; Shallis, R. M.; Podoltsev, N. A.; Huntington, S. F.; Zeidan, A. M.
    Blood (2022)

    Fulltext@MSK | Save
  • A review of FLT3 inhibitors in acute myeloid leukemia
    Review

    Zhao, J. C.; Agarwal, S.; Ahmad, H.; Amin, K.; Bewersdorf, J. P.; Zeidan, A. M.
    Blood Reviews (2022)

    Fulltext@MSK | Save
  • Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
    Journal Article

    Zeidan, A. M.; DeAngelo, D. J.; Palmer, J.; Seet, C. S.; Tallman, M. S.; Wei, X.; Raymon, H.; Sriraman, P.; Kopytek, S.; Bewersdorf, J. P.; more...
    Annals of Hematology (2022)

    Fulltext@MSK | Save
  • Azacitidine maintenance in AML post induction and posttransplant
    Review

    Bewersdorf, J. P.; Prebet, T.; Gowda, L.
    Current Opinion in Hematology (2022)

    Fulltext@MSK | Save